Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study

NCT04304105 is registered in ClinicalTrials.gov with LimFlow, Inc. as lead sponsor.

NCT NCT04304105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04304105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study
Lead sponsor
LimFlow, Inc.
Phase
Observational
Overall status
Completed
Start date
February 24, 2020
Completion date
September 12, 2022
Enrollment
192 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, peripheral artery disease